The hypothesis that mental function is based on biochemical activity in the nervous system has been substantiated by the suc cessful use of drugs in treating emotional and psychotic illnesses. The substances in cells which are largely responsible for the biochemical activity of the cell are the pro teins for they function as enzymes, hor mones or inert structural supports. Some molecular biologists (1) think that the protein macromolecules with their ability to undergo rapid reversible con figuration al changes will be prominent among the brain components involved in the molecular reactions of memory and learning. Neurochemists (24) have specu lated that proteins would be closely involved in the free amino acid metabolism, the ammonia metabolism and the electrolyte metabolism of the brain.
malian brain by electrophoretic techniques and found it to be composed of a formid able array of more than a hundred pro teins of different sizes and surface charge. However at McGill it was found that fewer than twenty of these proteins are antigenic and capable of stimulating the production of detectable levels of precipitating anti bodies in rabbits (14). It was discovered that over one half of the antigens could be found also in the soluble fractions of other rat organs and were therefore species-speci fic antigens. One third of the antigens were found in the soluble fractions prepared from the brains of several other species of mammals and were therefore organ-specific antigens. In addition a new type of antigen was discovered which had a dual specificity directed towards the organ and the species. These were designated 'species-restricted antigens of nervous tissue' or SKANT pro teins (13). SRANT antigens have since been found in bovine brain (8) and will be of particular value in studying the de-velopment of the brain in different species of mammals. For example, three SRANT proteins have been identified in rat brain; one of them is found in fetal brain and dis appears from the brain a few days after birth, while the concentrations of the other two rise slowly after birth and characterize the adult rat brain.
Because it was found that such a large proportion of the antigens in brain are species-specific (8, 11, 14, 19) extracts or suspensions of brain tissue can be expected to react with the sera of patients with auto immune diseases caused by lesions in other organs. For this reason, when clinical stu dies are undertaken to ascertain if there is a correlation between the incidence of neurologic or psychiatric disease and the presence of antibodies to brain components in patients' sera, it would be advisable to search for antibodies directed against either brain organ-antigens or the SRANT pro teins.
Extracts prepared from the cerebral cor tex, the hippocampus, the caudate nucleus and the cerebellum of rat brain were analyzed by immunodiffusion experiments with antisera to extracts of whole rat brain. It was found that all the regions of the cere brum contained the same antigens but that the cerebellum lacked at least four of the cerebral antigens. The SRANT proteins were found throughout the entire nervous system of the rat (13). These results do not exclude the possibility that different brain regions may contain antigens peculiar to them. On the other hand, they indicate that if such region specific antigens do exist they are minor antigenic components of the area.
These findings are difficult to reconcile with reports from the Soviet Union (20) or from Yugoslavia (16), which suggest the anatomically demarcated areas of the brain contain antigens restricted to those areas. For example, Milhailovic and Jankovic reported that after cats received intra ventricular injections of rabbit antisera raised against the soluble fraction of cat hippo campus or cat caudate nucleus, the electri cal activities of these areas of the cat brain were specifically depressed while the acti vities of the other brain areas were un affected. The authors did not absorb their anti-hippocampus serum or anti-caudate nucleus serum with extracts of the caudate nucleus or the hippocampus to remove antibodies to the common antigens. Thus the antisera could not have been specific for either of the regions and it is probable that the specificity of their results was not due to immunological factors.
Several in vitro experiments using cul tured cells have shown that antibrain anti bodies modify the ultrastructure and the electrical activity of the nervous tissue cells with which they make direct contact (5, 10, 25). Such antibodies are found in the sera of patients with multiple sclerosis (3, 4), animals with experimental allergic ence phalitis (12, 18) and animals immunized with the soluble fractions of brain (8, 11, 14, 19).
However, antibrain antibodies have not been found to cause clinical disease or his tological changes in the brains of the host in which they circulate. Our results indicate that the outcome of in vivo studies on the effect of specific humoral antibody may depend on the location of the antigen in the brain cell. For example, the rabbits used in our investigations of the soluble fraction of brain developed high levels of antibodies directed against organ specific antigens existing in their own brains. Yet they re mained healthy during the two to threeyear period when they were being immun ized. It would appear that the antigen in side the brain cells was not accessible to the antibody since serum antibody continu ously passes into the cerebrospinal fluid (CSF). It is known that the plasma mem brane of a cell is largely impermeable to all substances except the nutrients needed by the cell. Evidently, the large antibody molecule does not traverse the intact plasma membrane of a brain cell to reach its target antigen in the cytoplasm of the cell.
In spite of the evidence that circulating anti-brain antibodies were not harmful, there was speculation that such antibodies might cause behavioural changes by acting on the plasma membranes of neurons so as to alter their electrical properties. This December, 1970 IMMUNOCHEMISTRY AND THE BRAIN 643 speculation became more plausible when Dingle, Fell and Coombs (6) showed that antibody and complement may not neces sarily lyze cells in situ but may alter the permeability of the plasma membrane. Thus an antiserum could alter the permeability of the neuronal plasma membrane if it contained an antibody which was directed against an antigenic component of the membrane.
The foremost proponent of the hypo thesis that schizophrenia is an autoimmune disease is Robert Heath (9). He has re ported that there is an antibody in the sera of schizophrenic patients which is directed against an antigen in the septal area of the brain. The 7-globulin fraction of the sera from some of these patients will cause transient psychotic symptoms when it is injected into normal human volunteers and also cause specific electrical changes in the septal area of the brains of monkeys. Although the antigen must therefore be an organ-specific one it is apparently very labile for it has never been identified by immunodiffusion analyses in extracts of the septal region of human or monkey brain. The antibody in the schizophrenic sera must also have unusual properties as Heath re ports that it can cross the blood brain bar rier, the external cell membrane of a neuron and the neuronal nuclear membrane to re act with its target antigen in the neuronal nucleus within fifteen minutes after it has been injected into the blood stream. This reaction occurs without causing any detect able alterations in the two membranes con cerned.
In spite of the fact that the results of Heath and Jankovic cannot be reconciled on the basis of present-day knowledge of the properties of antibodies or brain anti gens, nevertheless the potential importance of their findings is too great to be ignored by neuroscientists. Thus, these works have stimulated the initiation of psycho-immunochemical studies earlier than otherwise might have been the case.
Experiments were undertaken to ascer tain whether isoantibodies to the microso mal fraction of rat brain cells circulating in the blood and CSF for at least a month could affect the ability of rats to learn a visual discrimination problem. The micro somal fraction of rat brain was chosen be cause rats responded rapidly to immuniza tion with this fragmented internal cell mem brane with measurable levels of complement fixing antibodies. There was also evidence from electron microscope studies that the external cell membrane and the endothelial reticulum or microsomal membrane of rat liver cells were morphologically continuous in certain areas and shared some enzymes and antigens (7). Since it was not feasible to conduct experiments with neuronal mem branes it was hoped that the liver cell would not be unique and that the neuronal plasma membrane and the neuronal microsomes would also have common antigens.
By using isoimmune animals, some of the hazards inherent in using heterologous antibrain sera were avoided. Thus the rat would not form antibodies against rat serum proteins or against any organ antigens having weak immunogenic powers in the rat. Furthermore, the antibodies in the serum equilibrate continuously with the antibody fraction in the CSF and would have the same transport characteristics vis-a-vis the membranes between the brain and the CSF as normal rat 7-globulin. This characteristic cannot be automatically assumed for hetero logous antibody.
Two groups of rats were used as con trols. One group was injected with saline solution while the other group was im munized with the microsomal fraction of rat liver. The subjects were trained in an elec trified two-choice discrimination apparatus, devised by Thompson (23) with shockavoidance as the motivation. They were given twenty trials a day until they were able to respond correctly eighteen times out of twenty.
The results of four experiments using a hundred rats indicated that after isoanti bodies to the antigens in the microsomal fraction of rat brain or rat liver had been circulating in the sera for a month, the animals learned a visual discrimination problem statistically significantly more slowly than control animals injected with saline (21). It was of great interest to find that the microsomal fraction from liver was just as effective as the microsomal fraction from the brain. Immunodiffusion studies (22) have confirmed that the solubilized micro somal fraction from rat liver and rat kid ney contain at least two antigens which are immunologically identical with antigens in the solubilized microsomal fraction from rat brain. This suggests that the species specific antigens in the microsomes are also present in the plasma membranes.
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The degree of impairment of learning ability varied from experiment to experi ment when actively immunized rats were studied. In the latest experiments, which are still exploratory in nature, elimination of some of the variables was achieved by in jecting a definite volume of isoantibody solution into the lateral ventricle of each animal through a permanently implanted cannula.
Experimental rats receiving 50 fA of the y-globulin fraction of a rat anti-rat liver microsome serum daily for eight days re quired a significantly greater number of trials in order to learn the visual discrimina tion problem than the rats injected with the normal rat y-globulin (15).
With this experimental procedure re sults were reproducible with different lots of animals. The rats appear to be healthy otherwise. They grow at a normal rate and do not exhibit any symptoms of neurologi cal disease. At present it is not known how the anti body causes the impairment of learning ability. The brains of animals injected with the antimicrosomal antibody are being examined by histochemical and electron microscope techniques to ascertain the iden tity and location of the brain cells affected. Immunochemical studies are also being carried out on the microsomal fractions of rat brain and rat liver to determine the antigens to which the rat responds. At the present time the anti-brain sera contain a mixture of antibodies of unknown specificity, but in future it should be pos sible to prepare a series of antisera, each containing an antibody directed to one com ponent of a particular kind of brain cell.
With such refined immunochemical re agents, it will be feasible to alter the proper ties of selected brain structures in vivo and to find out how this affects different kinds of brain function.
